PDCD1 and neoplasm: Programmed cell death ligand 1 (PD‐L1) is widely present in tumor cells and some immune cells (e.g. dendritic cells), and it is able to bind to PD‐1 of T lymphocytes, thus inhibiting the immune recognition function of T lymphocytes [65].